Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00103974
Status:
COMPLETED
Last Update Posted:
2008-04-07
First Post:
2005-02-17
Brief Title:
Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
Sponsor:
Bayhill Therapeutics
Organization:
Bayhill Therapeutics
Organization Data
Organization:
Bayhill Therapeutics
Class:
INDUSTRY
Study ID:
BHT-3009-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayhill Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None